Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2011-04-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archophthalmol.2011.42PMID 21482870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation

  2009cited by this paper
• ‘Chimeric’ Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant Survival

  2009cited by this paper
• GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.

  2009cited by this paper
• Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation

  2009cited by this paper
• Bevacizumab (Avastin) eye drops inhibit corneal neovascularization

  2008cited by this paper
• Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs.

  2008cited by this paper
• Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.

  2008cited by this paper
• Inflammation

  2008cited by this paper
• Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.

  2008cited by this paper
• Safety profile of topical VEGF neutralization at the cornea.

  2008cited by this paper
• The evolving role of vascular endothelial growth factor inhibitors in the treatment of neovascular age-related macular degeneration

  2008cited by this paper
• Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.

  2008cited by this paper
• Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.

  2007cited by this paper
• [Inhibition of angiogenesis in the anterior chamber of the eye].

  2007cited by this paper
• Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis.

  2007cited by this paper
• Corneal graft rejection.

  2007cited by this paper
• Immune privilege and angiogenic privilege of the cornea.

  2007cited by this paper
• Antiangiogene Therapie am vorderen Augenabschnitt

  2007cited by this paper
• Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.

  2007cited by this paper
• Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction.

  2006cited by this paper
• Time Course of Angiogenesis and Lymphangiogenesis After Brief Corneal Inflammation

  2006cited by this paper
• Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

  2006cited by this paper
• Angiogenesis and Lymphangiogenesis—Implications for Corneal Immunity

  2006cited by this paper
• Corneal avascularity is due to soluble VEGF receptor-1

  2006cited by this paper
• Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.

  2005cited by this paper
• Lymphangiogenesis in development and human disease

  2005cited by this paper
• Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

  2005cited by this paper
• VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.

  2004cited by this paper
• Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity

  2004cited by this paper
• Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.

  2004cited by this paper
• Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology

  2003cited by this paper
• Corneal neovascularization.

  2001cited by this paper
• Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty

  2001cited by this paper
• Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

  1999cited by this paper
• Topical modulation of interleukin-1 activity in corneal neovascularization.

  1998cited by this paper
• The EGF‐TM7 family: unusual structures at the leukocyte surface

  1998cited by this paper
• TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.

  1998cited by this paper
• Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction

  1997cited by this paper
• New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo.

  1996cited by this paper
• Loss and restoration of immune privilege in eyes with corneal neovascularization.

  1996cited by this paper
• Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.

  1995cited by this paper
• Steroid inhibition of limbal blood and lymphatic vascular cell growth.

  1995cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group.

  1994cited by this paper
• The metabolism of fluorometholone by bovine cornea.

  1993cited by this paper
• The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.

  1993cited by this paper
• Pharmacokinetics of ophthalmic corticosteroids.

  1992cited by this paper
• Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

  1987cited by this paper
• Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

  1987cited by this paper
• Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone.

  1981cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981cited by this paper
• THE SIDE EFFECTS OF CORTICOSTEROIDS.

  1964cited by this paper

• Thermosensitive Chitosan-Hyaluronic Acid Hydrogel for Sustained Betamethasone and Levofloxacin Delivery in Corneal Wound Healing.

  2026cites this paper
• Lymphatic Recovery and Clinical Implications in Hand Allotransplantation: Insights From Indocyanine Green Lymphangiography.

  2026cites this paper
• Quantitative Analysis of Orbital Soft Tissues Using Three‐Dimensional Fast Spin Echo With 2‐Point Dixon‐Based Fat Suppression Sequence: Its Association With Methylprednisolone Pulse Therapy Treatment Efficacy in Thyroid‐Associated Ophthalmopathy

  2025cites this paper
• Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157

  2025cites this paper
• Current progress in research on ocular injury caused by exposure to vesicants

  2025cites this paper
• Monitoring the Effectiveness of High-Fluence Peripheral Crosslinking for Corneal Neovascularization with Anterior Segment Optical Coherence Tomography Angiography

  2024cites this paper
• Glucocorticoid Receptor Signaling Is Critical for Mouse Corneal Development, Inhibition of Inflammatory Response, and Neovascularization of the Cornea.

  2024cites this paper
• Management of corneal neovascularization: Current and emerging therapeutic approaches

  2024cites this paper
• High-Throughput Transcriptomics screen of ToxCast chemicals in U-2 OS cells.

  2024cites this paper
• A Chemical Structure and Machine Learning Approach to Assess the Potential Bioactivity of Endogenous Metabolites and Their Association with Early Childhood Systemic Inflammation

  2024cites this paper
• Current trends in the management of corneal neovascularization

  2024cites this paper
• The novel role of lymphatic vessels in the pathogenesis of ocular diseases.

  2023cites this paper
• A chemical structure and machine learning approach to assess the potential bioactivity of endogenous metabolites and their association with early-childhood hs-CRP levels

  2023cites this paper
• A peptidic network antibody inhibits both angiogenesis and inflammatory response.

  2023cites this paper
• Myeloid-derived suppressor cells ameliorate Corneal Alkali Burn through IL-10-dependent anti-inflammatory properties.

  2023cites this paper
• Corneal neovascularization: a modern view of molecular mechanisms and methods of therapy

  2023cites this paper
• Future directions in managing aniridia-associated keratopathy.

  2023cites this paper
• The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model

  2023cites this paper
• Preventive treatment of allograft rejection after endothelial keratoplasty: A systematic review and meta‐analysis

  2022cites this paper
• Corneal Collagen Cross-Linking Inhibits Corneal Blood and Lymphatic Vessels Temporarily in Alkali-Burned Rabbits

  2022cites this paper
• Long-term survival in non-human primates of stem cell-derived, MHC-unmatched corneal epithelial cell sheets

  2022cites this paper
• Development of Multilayer Mesenchymal Stem Cell Cell Sheets

  2021cites this paper
• Importance of Corneal Angiography in Subclinical Limbitis in a Case of Atopic Keratoconjunctivitis

  2021cites this paper
• Macrophage-Mediated Tissue Vascularization: Similarities and Differences Between Cornea and Skin

  2021cites this paper
• Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival

  2021cites this paper
• The Role of Inflammatory Cytokines in Neovascularization of Chemical Ocular Injury

  2021cites this paper
• Corneal neovascularization.

  2020cites this paper
• The impact of corticosteroid therapy on the bacterial corneal ulcer healing process

  2020cites this paper
• Complex Approach to the Bacterial Corneal Ulcers Treatment

  2020cites this paper
• Clinical Trials of Limbal Stem Cell Deficiency Treated with Oral Mucosal Epithelial Cells

  2020cites this paper
• The progress in corneal translational medicine.

  2020cites this paper
• Steroid-eluting contact lenses for corneal and intraocular inflammation.

  2020cites this paper
• Topical VEGF-C/D Inhibition Prevents Lymphatic Vessel Ingrowth into Cornea but Does Not Improve Corneal Graft Survival

  2020cites this paper
• Supplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis

  2020cites this paper
• Inflammation and Lymphatic Function

  2019cites this paper
• Corneal lymphangiogenesis ameliorates corneal inflammation and edema in late stage of bacterial keratitis

  2019cites this paper
• Optical Coherence Tomography Angiography Imaging to monitor Anti-VEGF treatment of Corneal Vascularization in a Rabbit Model

  2019cites this paper
• Fluorometholone modulates gene expression of ocular surface mucins

  2019cites this paper
• Antiangiogenesis Effect of Albendazole on the Cornea

  2019cites this paper
• Corneal neovascularization: updates on pathophysiology, investigations & management

  2019cites this paper
• Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.

  2019cites this paper
• Notch Signaling Pathway Is Involved in bFGF-Induced Corneal Lymphangiogenesis and Hemangiogenesis

  2019cites this paper
• Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival

  2018cites this paper
• Comparison of Optical Coherence Tomography Angiography to Indocyanine Green Angiography and Slit Lamp Photography for Corneal Vascularization in an Animal Model

  2018cites this paper
• UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high‐risk corneal transplant survival

  2018cites this paper
• Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation

  2017cites this paper
• Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract.

  2017cites this paper
• Effect of sorafenib in a murine high risk penetrating keratoplasty model.

  2017cites this paper
• Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.

  2017cites this paper
• IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages.

  2016cites this paper
• Corneal Neovascular Diseases

  2016cites this paper
• Assessment of therapeutic options for reducing alkali burn-induced corneal neovascularization and inflammation.

  2016cites this paper
• Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

  2016cites this paper
• Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery.

  2016cites this paper
• Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?

  2015cites this paper
• Therapeutic methods of scar prevention at the site of endonasal dacryocystorhinostomy

  2015cites this paper
• Corneal neovascularization and contemporary antiangiogenic therapeutics

  2015cites this paper
• Corneal Neovascularization: A Translational Perspective

  2015cites this paper
• Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin

  2015cites this paper
• Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.

  2015cites this paper
• [Therapeutic methods of scar prevention at the site of endonasal dacryocystorhinostomy].

  2015cites this paper
• Therapeutics as well as Ophthalmology- Past- Present as well as Potential

  2015cites this paper
• Angiopoietin-Like 7 Is an Anti-Angiogenic Protein Required to Prevent Vascularization of the Cornea

  2015cites this paper
• Lymphangiogenesis and Inflammation—Looking for the “Missing Pieces” of the Puzzle

  2015cites this paper
• In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications.

  2014cites this paper
• Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.

  2014influential citation
• Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction

  2014cites this paper
• Transgenic mouse models of corneal neovascularization: new perspectives for angiogenesis research.

  2014cites this paper
• High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty.

  2014cites this paper
• Correction: Short-Term Azithromycin Treatment Promotes Cornea Allograft Survival in the Rat

  2014cites this paper
• Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.

  2013cites this paper
• Antiangiogene Präkonditionierung vor Keratoplastik

  2013cites this paper
• Cornea Serum Eyedrops Antagonize the Anti ( lymph ) angiogenic Effects of Bevacizumab In Vitro and In Vivo

  2013cites this paper
• Antiangiogenic Treatment Options in the Cornea

  2013cites this paper
• Corneal oedema and its medical treatment

  2013cites this paper
• [Anti(lymph)angiogenic preconditioning prior to keratoplasty].

  2013cites this paper
• The association between corneal neovascularization and visual acuity: a systematic review

  2013cites this paper
• Immunreaktionen nach DMEK, DSAEK und DALK

  2013cites this paper
• Immunsuppression nach Keratoplastik Present State of the Art in Topical and Systemic Immunosuppression after Keratoplasty

  2013cites this paper
• Short- and long-term corneal vascular effects of tafluprost eye drops

  2013cites this paper
• Presurgical Corticosteroid Treatment Improves Corneal Transplant Survival in Mice

  2013cites this paper
• [Prevention and management of complications in Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK)].

  2013cites this paper
• Lymphatic vessels: new targets for the treatment of inflammatory diseases

  2013cites this paper
• Sunitinib inhibits inflammatory corneal lymphangiogenesis.

  2013cites this paper
• Short-Term Azithromycin Treatment Promotes Cornea Allograft Survival in the Rat

  2013cites this paper
• Aktueller Stand der lokalen und systemischen Immunsuppression nach Keratoplastik

  2013cites this paper
• Corneal neovascularization: a review of the molecular biology and current therapies

  2013cites this paper
• Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.

  2013cites this paper
• Emerging techniques to treat corneal neovascularisation

  2012cites this paper
• Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.

  2012cites this paper
• Corneal angiogenesis and lymphangiogenesis

  2012cites this paper
• Effect of Glucocorticoid (Triamcinolone Acetonide) Pretreatment in a Murine Penetrating Keratoplasty and Suture Model

  2012cites this paper
• Angiogenesis from a new perspective

  2012cites this paper
• Recent Advances in Ocular Nucleic Acid-Based Therapies: The Silent Era

  2012cites this paper
• Ethyl pyruvate ameliorates endotoxin-induced corneal inflammation.

  2012cites this paper
• Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model.

  2012cites this paper
• Gamma-irradiation reduces the allogenicity of donor corneas.

  2012cites this paper
• In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis

  2012cites this paper
• Salient Features of New Therapies in Ophthalmology

  2011cites this paper
• Enfoque actual del empleo de corticoesteroides en la terapéutica ocular. Current Approach of Corticosteroids Use in Ocular Therapy.

  2011cites this paper